BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho AF, Maes M, Walder K, Berk M. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach. Life Sci. 2020;258:118166. [PMID: 32739471 DOI: 10.1016/j.lfs.2020.118166] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Farella I, Panza R, Capozza M, Laforgia N. Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19? Biomed Pharmacother 2021;141:111922. [PMID: 34323703 DOI: 10.1016/j.biopha.2021.111922] [Reference Citation Analysis]
2 Paiz N, Alonso P, Portillo AL. Vitamin D Status: Can It Affect the Risk of Infection and the Severity of COVID-19 Symptoms? Curr Trop Med Rep 2021;:1-8. [PMID: 33816060 DOI: 10.1007/s40475-021-00236-3] [Reference Citation Analysis]
3 Land WG. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia. Genes Immun 2021;22:141-60. [PMID: 34140652 DOI: 10.1038/s41435-021-00140-w] [Reference Citation Analysis]
4 Morris G, Berk M, Walder K, O'Neil A, Maes M, Puri BK. The lipid paradox in neuroprogressive disorders: Causes and consequences. Neurosci Biobehav Rev 2021;128:35-57. [PMID: 34118292 DOI: 10.1016/j.neubiorev.2021.06.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Toor D, Jain A, Kalhan S, Manocha H, Sharma VK, Jain P, Tripathi V, Prakash H. Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease. Front Pharmacol 2020;11:570698. [PMID: 33178021 DOI: 10.3389/fphar.2020.570698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ruaro B, Salton F, Braga L, Wade B, Confalonieri P, Volpe MC, Baratella E, Maiocchi S, Confalonieri M. The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung. Int J Mol Sci 2021;22:2566. [PMID: 33806395 DOI: 10.3390/ijms22052566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
7 Gherlone EF, Polizzi E, Tetè G, De Lorenzo R, Magnaghi C, Rovere Querini P, Ciceri F. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19. J Dent Res 2021;100:464-71. [PMID: 33655804 DOI: 10.1177/0022034521997112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
8 Tan DX, Hardeland R. Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19. Molecules 2020;25:E4410. [PMID: 32992875 DOI: 10.3390/molecules25194410] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Hui KP, Cheung MC, Lai KL, Ng KC, Ho JC, Peiris M, Nicholls JM, Chan MC. Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection. Clin Infect Dis 2021:ciab406. [PMID: 33956935 DOI: 10.1093/cid/ciab406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Johnson AM, Barigye R, Saminathan H. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases. Hum Vaccin Immunother 2021;17:2824-40. [PMID: 33974497 DOI: 10.1080/21645515.2021.1908060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dutta S, Mukherjee A, Nongthomba U. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. Cytokine Growth Factor Rev 2022:S1359-6101(22)00002-8. [PMID: 35039221 DOI: 10.1016/j.cytogfr.2022.01.002] [Reference Citation Analysis]
12 Shimizu Y. Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy. World J Clin Cases 2020; 8(23): 5835-5843 [PMID: 33344582 DOI: 10.12998/wjcc.v8.i23.5835] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Calkovska A, Kolomaznik M, Calkovsky V. Alveolar type II cells and pulmonary surfactant in COVID-19 era. Physiol Res 2021;70:S195-208. [PMID: 34913352 DOI: 10.33549/physiolres.934763] [Reference Citation Analysis]
14 Xu C, Li L, Wang W. Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic. Technol Cancer Res Treat 2021;20:15330338211050764. [PMID: 34657503 DOI: 10.1177/15330338211050764] [Reference Citation Analysis]
15 Sukkar SG, Cogorno L, Pisciotta L, Pasta A, Vena A, Gradaschi R, Dentone C, Guiddo E, Martino E, Beltramini S, Donini LM, Carmisciano L, Sormani MP, Bassetti M; GECOVID Study Group. Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission. Nutrition 2021;89:111236. [PMID: 33895559 DOI: 10.1016/j.nut.2021.111236] [Reference Citation Analysis]
16 Konduri KS, Pattisapu R, Pattisapu J, Konduri GG, Zwetchkenbaum J, Roy B, Barman M, Frazier A, Hurst BL, Düzgüneş N. ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation. Arch Pharmacol Ther 2021;3:52-65. [PMID: 34766166 DOI: 10.33696/pharmacol.3.028] [Reference Citation Analysis]
17 Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton GD, Oliveira MF, Adam RD, Aziminia N, Menacho K, Chacko L, Brown JT, Patel RK, Shiwani H, Bhuva A, Augusto JB, Andiapen M, McKnight A, Noursadeghi M, Pierce I, Evain T, Captur G, Davies RH, Greenwood JP, Fontana M, Kellman P, Schelbert EB, Treibel TA, Manisty C, Moon JC; COVIDsortium Investigators. Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers. JACC Cardiovasc Imaging 2021:S1936-878X(21)00356-9. [PMID: 33975819 DOI: 10.1016/j.jcmg.2021.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Brendler T, Al‐harrasi A, Bauer R, Gafner S, Hardy ML, Heinrich M, Hosseinzadeh H, Izzo AA, Michaelis M, Nassiri‐asl M, Panossian A, Wasser SP, Williamson EM. Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice. Phytotherapy Research 2021;35:3013-31. [DOI: 10.1002/ptr.7008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
21 Dermarkarian CR, Chilakapati M, Hussein M, Chévez-Barrios P, Allen RC. Bilateral orbital inflammation in a 6-month old with SARS-CoV-2 infection. Orbit 2021;:1-4. [PMID: 33874837 DOI: 10.1080/01676830.2021.1914670] [Reference Citation Analysis]
22 Nabi-Afjadi M, Karami H, Goudarzi K, Alipourfard I, Bahreini E. The effect of vitamin D, magnesium and zinc supplements on interferon signaling pathways and their relationship to control SARS-CoV-2 infection. Clin Mol Allergy 2021;19:21. [PMID: 34749737 DOI: 10.1186/s12948-021-00161-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Etemad-Moghadam S, Alaeddini M. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature. Int J Dent 2021;2021:6648082. [PMID: 34054961 DOI: 10.1155/2021/6648082] [Reference Citation Analysis]
24 Jafari A, Sadeghpour S, Ghasemnejad-Berenji H, Pashapour S, Ghasemnejad-Berenji M. Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection. Int J Pept Res Ther 2021;:1-9. [PMID: 33880115 DOI: 10.1007/s10989-021-10217-9] [Reference Citation Analysis]
25 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
26 Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. The Role of Alveolar Edema in COVID-19. Cells 2021;10:1897. [PMID: 34440665 DOI: 10.3390/cells10081897] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Kuindersma M, Diaz RR, Spronk PE. Tailored modulation of the inflammatory balance in COVID-19 patients admitted to the ICU?-a viewpoint. Crit Care 2021;25:178. [PMID: 34034789 DOI: 10.1186/s13054-021-03607-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Vlahopoulos S, Wang K, Xue Y, Zheng X, Boldogh I, Pan L. Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections. Cells 2021;10:3067. [PMID: 34831290 DOI: 10.3390/cells10113067] [Reference Citation Analysis]
29 Cloer C, Roudsari L, Rochelle L, Petrie T, Welch M, Charest J, Tan K, Fugang L, Petersen T, Ilagan R, Hogan S. Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19. PLoS One 2021;16:e0259732. [PMID: 34780505 DOI: 10.1371/journal.pone.0259732] [Reference Citation Analysis]
30 Julian DR, Kazakoff MA, Patel A, Jaynes J, Willis MS, Yates CC. Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19. Curr Pathobiol Rep 2021;:1-13. [PMID: 34900402 DOI: 10.1007/s40139-021-00226-0] [Reference Citation Analysis]
31 Poyraz BM, Engin ED, Engin AB, Engin A. The effect of environmental diesel exhaust pollution on SARS-CoV-2 infection: The mechanism of pulmonary ground glass opacity. Environ Toxicol Pharmacol 2021;86:103657. [PMID: 33838330 DOI: 10.1016/j.etap.2021.103657] [Reference Citation Analysis]